Shenouda Maged purchased 120,200 shares of RLMD

Form 4 filed Sep 11, 2026 · transaction dated Sep 9, 2026

Shares
120,200
Share price
$4.20
Transaction value
$504,840
Score
Score hidden. Sign up to see this filing's FilingIQ Score.
Sign up to view →

What happened

On Sep 9, 2026, Shenouda Maged, Chief Financial Officer purchased 120,200 shares of RLMD (RELMADA THERAPEUTICS, INC.) at $4.20 per share. The transaction was filed under SEC Form 4 transaction code P, for a total transaction value of $504,840.

This filing made the top-scored cut on FilingIQ's multi-factor signal model, which weighs insider context (seniority, prior conviction history), trade structure (transaction code, plan status, position sizing), and market environment together. The methodology is documented at methodology. Sign up to see this trade's Score and full dimension breakdown.

The raw filing is on SEC EDGAR at https://www.sec.gov/Archives/edgar/data/1553643/000121390026098970/0001213900-26-098970-index.htm. The accession number is 0001213900-26-098970.

Related

Ticker
RLMD RELMADA THERAPEUTICS, INC.

Methodology and sources

This page summarizes a single SEC Form 4 disclosure. The underlying XML is publicly filed by the issuer and available on SEC EDGAR at the link above. FilingIQ does not modify the underlying filing; this page is a normalized rendering with cross-references and a FilingIQ Score. Author: Niklas Feldmann. Scoring methodology: methodology. Not investment advice; see disclaimer.